Search Results - "Hallett, Timothy B"

Refine Results
  1. 1

    Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model by Heffernan, Alastair, Cooke, Graham S, Nayagam, Shevanthi, Thursz, Mark, Hallett, Timothy B

    Published in The Lancet (British edition) (30-03-2019)
    “…The revolution in hepatitis C virus (HCV) treatment through the development of direct-acting antivirals (DAAs) has generated international interest in the…”
    Get full text
    Journal Article
  2. 2

    Future challenges for clinical care of an ageing population infected with HIV: a modelling study by Smit, Mikaela, Dr, Brinkman, Kees, MD, Geerlings, Suzanne, MD, Smit, Colette, PhD, Thyagarajan, Kalyani, PhD, Sighem, Ard van, PhD, de Wolf, Frank, Prof, Hallett, Timothy B, Prof

    Published in The Lancet infectious diseases (01-07-2015)
    “…Summary Background The population infected with HIV is getting older and these people will increasingly develop age-related non-communicable diseases (NCDs)…”
    Get full text
    Journal Article
  3. 3

    Requirements for global elimination of hepatitis B: a modelling study by Nayagam, Shevanthi, Dr, Thursz, Mark, Prof, Sicuri, Elisa, PhD, Conteh, Lesong, PhD, Wiktor, Stefan, MD, Low-Beer, Daniel, PhD, Hallett, Timothy B, Prof

    Published in The Lancet infectious diseases (01-12-2016)
    “…Summary Background Despite the existence of effective prevention and treatment interventions, hepatitis B virus (HBV) infection continues to cause nearly 1…”
    Get full text
    Journal Article
  4. 4

    The impact of the timely birth dose vaccine on the global elimination of hepatitis B by de Villiers, Margaret J., Nayagam, Shevanthi, Hallett, Timothy B.

    Published in Nature communications (28-10-2021)
    “…In 2016 the World Health Organization set the goal of eliminating hepatitis B globally by 2030. Horizontal transmission has been greatly reduced in most…”
    Get full text
    Journal Article
  5. 5

    Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? by Cohen, Myron S, Prof, Smith, M Kumi, MPH, Muessig, Kathryn E, PhD, Hallett, Timothy B, Prof, Powers, Kimberly A, PhD, Kashuba, Angela D, Prof

    Published in The Lancet (British edition) (02-11-2013)
    “…Summary Antiretroviral drugs that inhibit viral replication were expected to reduce transmission of HIV by lowering the concentration of HIV in the genital…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Mathematical models in the evaluation of health programmes by Garnett, Geoffrey P, Prof, Cousens, Simon, Prof, Hallett, Timothy B, PhD, Steketee, Richard, MD, Walker, Neff, Dr

    Published in The Lancet (British edition) (06-08-2011)
    “…Summary Modelling is valuable in the planning and evaluation of interventions, especially when a controlled trial is ethically or logistically impossible…”
    Get full text
    Journal Article
  9. 9

    Epidemiological metrics and benchmarks for a transition in the HIV epidemic by Ghys, Peter D, Williams, Brian G, Over, Mead, Hallett, Timothy B, Godfrey-Faussett, Peter

    Published in PLoS medicine (01-10-2018)
    “…Peter Godfrey-Faussett and colleagues present six epidemiological metrics for tracking progress in reducing the public health threat of HIV…”
    Get full text
    Journal Article
  10. 10

    Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings by DODD, Peter J, GARNETT, Geoff P, HALLETT, Timothy B

    Published in AIDS (London) (13-03-2010)
    “…It has been suggested that a new strategy for HIV prevention, 'Universal Test and Treat', whereby everyone is tested for HIV once a year and treated…”
    Get full text
    Journal Article
  11. 11

    The long-term impact and value of curative therapy for HIV: a modelling analysis by Guzauskas, Gregory F, Hallett, Timothy B

    Published in Journal of the International AIDS Society (01-09-2023)
    “…Curative therapies (CTx) to achieve durable remission of HIV disease without the need for antiretroviral therapy (ART) are currently being explored. Our…”
    Get full text
    Journal Article
  12. 12

    Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence by Eaton, Jeffrey W., Hallett, Timothy B.

    “…Significance Antiretroviral treatment (ART), which prevents both morbidity and HIV transmission for persons infected with HIV, is now thought to be central to…”
    Get full text
    Journal Article
  13. 13

    The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis by Morgan, George, Back, Emily, Besser, Martin, Hallett, Timothy B., Guzauskas, Gregory F.

    Published in Scientific reports (01-02-2024)
    “…Sickle cell disease (SCD) is an inherited, progressively debilitating blood disorder. Emerging gene therapies (GTx) may lead to a complete remission, the…”
    Get full text
    Journal Article
  14. 14

    Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study by Hontelez, Jan A C, Lurie, Mark N, Bärnighausen, Till, Bakker, Roel, Baltussen, Rob, Tanser, Frank, Hallett, Timothy B, Newell, Marie-Louise, de Vlas, Sake J

    Published in PLoS medicine (01-10-2013)
    “…Expanded access to antiretroviral therapy (ART) using universal test and treat (UTT) has been suggested as a strategy to eliminate HIV in South Africa within 7…”
    Get full text
    Journal Article
  15. 15

    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis by Ricks, Saskia, Denkinger, Claudia M, Schumacher, Samuel G, Hallett, Timothy B, Arinaminpathy, Nimalan

    Published in PLoS medicine (11-12-2020)
    “…Lateral flow urine lipoarabinomannan (LAM) tests could offer important new opportunities for the early detection of tuberculosis (TB). The currently licensed…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China by Heffernan, Alastair, Ma, Yanling, Nayagam, Shevanthi, Chan, Polin, Chen, Zhongdan, Cooke, Graham S, Guo, Yan, Liu, Chuntao, Thursz, Mark, Zhang, Wanyue, Zhang, Xiaobing, Zhang, Xiujie, Jia, Manhong, Hallett, Timothy B

    Published in PloS one (13-01-2021)
    “…The paradigm shift in hepatitis C virus (HCV) treatment options in the last five years has raised the prospect of eliminating the disease as a global health…”
    Get full text
    Journal Article
  18. 18

    Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: A modelling study by Jewell, Britta L., Smith, Jennifer A., Hallett, Timothy B.

    Published in EClinicalMedicine (01-09-2020)
    “…There is concern that the COVID-19 pandemic could severely disrupt HIV services in sub-Saharan Africa. However, it is difficult to determine priorities for…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006-2015 by Mangal, Tara D, Meireles, Mariana Veloso, Pascom, Ana Roberta Pati, de Almeida Coelho, Ronaldo, Benzaken, Adele Schwartz, Hallett, Timothy B

    Published in BMC infectious diseases (28-02-2019)
    “…We compared AIDS-related mortality rates in people living with HIV (PLHIV) starting antiretroviral therapy (ART) in Brazil during 2006-2015 and examined…”
    Get full text
    Journal Article